This publication is currently available for pre-order and electronic download only.
This Executive Summary provides an overview of the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder, and a quick reference to the key messages presented in the five-part “Medications for Opioid Use Disorder” Treatment Improvement Protocol (TIP). Invento
See all stories on this topic
Part 1 of this Treatment Improvement Protocol (TIP) offers a general introduction to providing medications to address opioid use disorder (OUD). It is for all audiences. Part 1 will help readers understand key facts and issues related to providing Food and Drug Administration (FDA)-approved medications used to treat OUD. TIP Parts 2 through 5 cover these issues in more detail. Inventory#: SMA18-50
See all stories on this topic
This publication is currently available for pre-order and electronic download only.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. Inventory#: SMA18-
See all stories on this topic
Price: (shipping charges may apply) Standard shipping is free. Expedited delivery has associated costs. You will be able to review shipping options and costs during check-out. Part 5 of this Treatment Improvement Protocol (TIP) provides an audience-segmented collection of resources and a glossary of key terms related to opioid use disorder. Standard shipping is free. Expedited delivery has assoc
See all stories on this topic
Part 3 of this Treatment Improvement Protocol (TIP) describes general principles of opioid use disorder (OUD) pharmacotherapy and discusses medication formulations, indications, and dosing for the three Food and Drug Administration (FDA)-approved medications used to treat
OUD—methadone, naltrexone, and buprenorphine. Part 3 also discusses patient management and monitoring in outpatient settings
See all stories on this topic
Be First to Comment